BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36457318)

  • 1. COVID-19 vaccine response and safety in patients with cancer: An overview of systematic reviews.
    Sun H; Bu F; Li L; Zhang X; Yan J; Huang T
    Front Public Health; 2022; 10():1072137. PubMed ID: 36457318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety, Immunogenicity, and Efficacy of COVID-19 Vaccines in Adolescents, Children, and Infants: A Systematic Review and Meta-Analysis.
    Du Y; Chen L; Shi Y
    Front Public Health; 2022; 10():829176. PubMed ID: 35493393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review and meta-analysis of the effectiveness and safety of COVID-19 vaccination in older adults.
    Xu K; Wang Z; Qin M; Gao Y; Luo N; Xie W; Zou Y; Wang J; Ma X
    Front Immunol; 2023; 14():1113156. PubMed ID: 36936964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis.
    Lee ARYB; Wong SY; Chai LYA; Lee SC; Lee MX; Muthiah MD; Tay SH; Teo CB; Tan BKJ; Chan YH; Sundar R; Soon YY
    BMJ; 2022 Mar; 376():e068632. PubMed ID: 35236664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of COVID-19 vaccine response in patients with cancer: An interim analysis.
    Tran S; Truong TH; Narendran A
    Eur J Cancer; 2021 Dec; 159():259-274. PubMed ID: 34798454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effectiveness of COVID-19 vaccines in reducing the incidence, hospitalization, and mortality from COVID-19: A systematic review and meta-analysis.
    Rahmani K; Shavaleh R; Forouhi M; Disfani HF; Kamandi M; Oskooi RK; Foogerdi M; Soltani M; Rahchamani M; Mohaddespour M; Dianatinasab M
    Front Public Health; 2022; 10():873596. PubMed ID: 36091533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 Vaccination in Patients With Malignancy; A Systematic Review and Meta-Analysis of the Efficacy and Safety.
    Javadinia SA; Alizadeh K; Mojadadi MS; Nikbakht F; Dashti F; Joudi M; Harati H; Welsh JS; Farahmand SA; Attarian F
    Front Endocrinol (Lausanne); 2022; 13():860238. PubMed ID: 35586627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Misinformation About COVID-19 Vaccines on Social Media: Rapid Review.
    Skafle I; Nordahl-Hansen A; Quintana DS; Wynn R; Gabarron E
    J Med Internet Res; 2022 Aug; 24(8):e37367. PubMed ID: 35816685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The vaccine journey for COVID-19: a comprehensive systematic review of current clinical trials in humans.
    Checcucci E; Piramide F; Pecoraro A; Amparore D; Campi R; Fiori C; Elhage O; Kotecha P; Vyakarnam A; Serni S; Dasgupta P; Porpiglia F
    Panminerva Med; 2022 Mar; 64(1):72-79. PubMed ID: 32456404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Therapy in Patients with Hematologic Malignancies on Seroconversion Rates After SARS-CoV-2 Vaccination.
    Guven DC; Sahin TK; Akın S; Uckun FM
    Oncologist; 2022 Apr; 27(4):e357-e361. PubMed ID: 35274729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody response to a third booster dose of SARS-CoV-2 vaccination in adults with haematological and solid cancer: a systematic review.
    Al Hajji Y; Taylor H; Starkey T; Lee LYW; Tilby M
    Br J Cancer; 2022 Nov; 127(10):1827-1836. PubMed ID: 36224402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of vaccination against SARS-CoV-2 and the need for alternative preventative approaches in immunocompromised individuals: a narrative review of systematic reviews.
    Tan TT; Ng HJ; Young B; Khan BA; Shetty V; Azmi N; Clissold S
    Expert Rev Vaccines; 2023; 22(1):341-365. PubMed ID: 36920116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and immunogenicity following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a secondary analysis of a randomised, placebo-controlled, phase 2 trial.
    Mallory RM; Formica N; Pfeiffer S; Wilkinson B; Marcheschi A; Albert G; McFall H; Robinson M; Plested JS; Zhu M; Cloney-Clark S; Zhou B; Chau G; Robertson A; Maciejewski S; Hammond HL; Baracco L; Logue J; Frieman MB; Smith G; Patel N; Glenn GM;
    Lancet Infect Dis; 2022 Nov; 22(11):1565-1576. PubMed ID: 35963274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and safety of SARS-CoV-2 vaccine in hemodialysis patients: A systematic review and meta-analysis.
    Peiyao R; Mengjie Y; Xiaogang S; Wenfang H; Danna Z; Yuqun Z; Juan J; Qiang H
    Front Public Health; 2022; 10():951096. PubMed ID: 36211647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): a trial conducted within the VACCELERATE network.
    Neuhann JM; Stemler J; Carcas A; Frías-Iniesta J; Bethe U; Heringer S; Tischmann L; Zarrouk M; Cüppers A; König F; Posch M; Cornely OA
    Trials; 2022 Oct; 23(1):865. PubMed ID: 36209129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney health in the COVID-19 pandemic: An umbrella review of meta-analyses and systematic reviews.
    Yang L; Li J; Wei W; Yi C; Pu Y; Zhang L; Cui T; Ma L; Zhang J; Koyner J; Zhao Y; Fu P
    Front Public Health; 2022; 10():963667. PubMed ID: 36172213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroconversion rate after vaccination against COVID-19 in patients with cancer-a systematic review.
    Corti C; Antonarelli G; Scotté F; Spano JP; Barrière J; Michot JM; André F; Curigliano G
    Ann Oncol; 2022 Feb; 33(2):158-168. PubMed ID: 34718117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Vaccination Worldwide on SARS-CoV-2 Infection: A Review on Vaccine Mechanisms, Results of Clinical Trials, Vaccinal Coverage and Interactions with Novel Variants.
    Damasceno DHP; Amaral AA; Silva CA; Simões E Silva AC
    Curr Med Chem; 2022; 29(15):2673-2690. PubMed ID: 34473613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for COVID-19 among healthcare workers. A protocol for a systematic review and meta-analysis.
    Dzinamarira T; Mhango M; Dzobo M; Ngara B; Chitungo I; Makanda P; Atwine J; Nkambule SJ; Musuka G
    PLoS One; 2021; 16(5):e0250958. PubMed ID: 33945546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.